Flagship Ventures Fund Iv, L.p. - Net Worth and Insider Trading
Flagship Ventures Fund Iv, L.p. Net Worth
The estimated net worth of Flagship Ventures Fund Iv, L.p. is at least $1.7 Billion dollars as of 2024-12-29. Flagship Ventures Fund Iv, L.p. is the 10% Owner of Moderna Inc and owns about 41,261,351 shares of Moderna Inc (MRNA) stock worth over $1.7 Billion. Flagship Ventures Fund Iv, L.p. is the 10% Owner of Rubius Therapeutics Inc and owns about 38,506,526 shares of Rubius Therapeutics Inc (RUBY) stock worth over $2 Million. Flagship Ventures Fund Iv, L.p. is also the 10% Owner of Axcella Health Inc and owns about 1,170,062 shares of Axcella Health Inc (AXLA) stock worth over $469,078. Besides these, Flagship Ventures Fund Iv, L.p. also holds Evelo Biosciences Inc (EVLO) , Kaleido Biosciences Inc (KLDO) . Details can be seen in Flagship Ventures Fund Iv, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Flagship Ventures Fund Iv, L.p. has not made any transactions after 2023-07-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Flagship Ventures Fund Iv, L.p.
Flagship Ventures Fund Iv, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Flagship Ventures Fund Iv, L.p. owns 12 companies in total, including Moderna Inc (MRNA) , Evelo Biosciences Inc (EVLO) , and Kaleido Biosciences Inc (KLDO) among others .
Click here to see the complete history of Flagship Ventures Fund Iv, L.p.’s form 4 insider trades.
Insider Ownership Summary of Flagship Ventures Fund Iv, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRNA | Moderna Inc | 2020-05-22 | 10 percent owner |
| EVLO | Evelo Biosciences Inc | 2023-07-11 | 10 percent owner |
| KLDO | Kaleido Biosciences Inc | 2021-02-08 | 10 percent owner |
 | | 2022-10-13 | 10 percent owner |
| | 2019-05-01 | 10 percent owner |
| | 2021-03-19 | 10 percent owner |
| | 2017-08-17 | 10 percent owner |
| | 2016-09-06 | 10 percent owner |
| | 2016-08-11 | 10 percent owner |
| | 2020-11-23 | 10 percent owner |
| | 2014-08-06 | 10 percent owner |
| | 2016-09-06 | 10 percent owner |
Flagship Ventures Fund Iv, L.p. Latest Holdings Summary
Flagship Ventures Fund Iv, L.p. currently owns a total of 5 stocks. Among these stocks, Flagship Ventures Fund Iv, L.p. owns 41,261,351 shares of Moderna Inc (MRNA) as of May 22, 2020, with a value of $1.7 Billion and a weighting of 99.84%. Flagship Ventures Fund Iv, L.p. owns 38,506,526 shares of Rubius Therapeutics Inc (RUBY) as of March 19, 2021, with a value of $2 Million and a weighting of 0.13%. Flagship Ventures Fund Iv, L.p. also owns 1,170,062 shares of Axcella Health Inc (AXLA) as of October 13, 2022, with a value of $469,078 and a weighting of 0.03%. The other 2 stocks Evelo Biosciences Inc (EVLO) , Kaleido Biosciences Inc (KLDO) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Flagship Ventures Fund Iv, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRNA | Moderna Inc | 2020-05-22 | 41,261,351 | 40.13 | 1,655,818,016 |
| RUBY | Rubius Therapeutics Inc | 2021-03-19 | 38,506,526 | 0.06 | 2,194,872 |
| AXLA | Axcella Health Inc | 2022-10-13 | 1,170,062 | 0.40 | 469,078 |
| EVLO | Evelo Biosciences Inc | 2023-07-11 | 7,932,624 | 0.00 | 3,966 |
| KLDO | Kaleido Biosciences Inc | 2021-02-08 | 19,575,710 | 0.00 | 1,958 |
Holding Weightings of Flagship Ventures Fund Iv, L.p.
Flagship Ventures Fund Iv, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Flagship Ventures Fund Iv, L.p. has made a total of 1 transactions in Moderna Inc (MRNA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Moderna Inc is the sale of 1,000,000 shares on May 22, 2020, which brought Flagship Ventures Fund Iv, L.p. around $68 Million.
According to the SEC Form 4 filings, Flagship Ventures Fund Iv, L.p. has made a total of 1 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Rubius Therapeutics Inc is the acquisition of 210,000 shares on March 19, 2021, which cost Flagship Ventures Fund Iv, L.p. around $6 Million.
According to the SEC Form 4 filings, Flagship Ventures Fund Iv, L.p. has made a total of 3 transactions in Axcella Health Inc (AXLA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Axcella Health Inc is the acquisition of 415,350 shares on October 13, 2022, which cost Flagship Ventures Fund Iv, L.p. around $17 Million.
More details on Flagship Ventures Fund Iv, L.p.'s insider transactions can be found in the Insider Trading History of Flagship Ventures Fund Iv, L.p. table.Insider Trading History of Flagship Ventures Fund Iv, L.p.
- 1
Flagship Ventures Fund Iv, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Flagship Ventures Fund Iv, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Flagship Ventures Fund Iv, L.p. is -13.45%. GuruFocus also compares Flagship Ventures Fund Iv, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Flagship Ventures Fund Iv, L.p. within 3 months outperforms 3 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Flagship Ventures Fund Iv, L.p.'s insider trading performs compared to the benchmark.
Performance of Flagship Ventures Fund Iv, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.83 | | | | | |
| Relative Return to S&P 500(%) | 8.59 | | | | | |
Flagship Ventures Fund Iv, L.p. Ownership Network
Flagship Ventures Fund Iv, L.p. Owned Company Details
What does Moderna Inc do?
Who are the key executives at Moderna Inc?
Flagship Ventures Fund Iv, L.p. is the 10 percent owner of Moderna Inc. Other key executives at Moderna Inc include Chief Legal Officer Shannon Thyme Klinger , President Stephen Hoge , and Chief Financial Officer James M Mock .
Moderna Inc (MRNA) Insider Trades Summary
Over the past 18 months, Flagship Ventures Fund Iv, L.p. made no insider transaction in Moderna Inc (MRNA). Other recent insider transactions involving Moderna Inc (MRNA) include a net sale of 727,832 shares made by Noubar Afeyan , a net sale of 199,642 shares made by Stephen Hoge , and a net sale of 13,661 shares made by Shannon Thyme Klinger .
In summary, during the past 3 months, insiders sold 5,076 shares of Moderna Inc (MRNA) in total and bought 0 shares, with a net sale of 5,076 shares. During the past 18 months, 978,871 shares of Moderna Inc (MRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 978,871 shares.
Moderna Inc (MRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Moderna Inc Insider Transactions
Flagship Ventures Fund Iv, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Flagship Ventures Fund Iv, L.p.. You might contact Flagship Ventures Fund Iv, L.p. via mailing address: 55 Cambridge Parkway, 8th Floor, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
